Publicado

2007-07-01

Factores pronósticos de esquizofrenia en primer episodio psicótico

Prognostic factors for schizophrenia during first psychotic episode

Palabras clave:

Esquizofrenia, trastornos psicóticos, pronóstico, diagnóstico precoz (es)
Schizophrenia, psychotic disorder, prognosis, early diagnosis (en)

Descargas

Autores/as

  • Juan F. Cano Centro de investigaciones de investigaciones del sistema nervioso (CISNE).
  • Marco Fierro-Urresta Centro de investigaciones de investigaciones del sistema nervioso (CISNE)
  • Claudia R. Vanegas Centro de investigaciones de investigaciones del sistema nervioso (CISNE).
  • Marcela Alzate Centro de investigaciones de investigaciones del sistema nervioso (CISNE).
  • Ana Olarte Centro de investigaciones de investigaciones del sistema nervioso (CISNE).
  • Ricardo Cendales Centro de investigaciones de investigaciones del sistema nervioso (CISNE).
  • Rodrigo N. Córdoba Centro de investigaciones de investigaciones del sistema nervioso (CISNE).

Objetivo. Revisar la literatura disponible sobre el pronóstico del primer episodio psicótico para el desarrollo de esquizofrenia.
Método. Una revisión sistemática de los estudios que han evaluado los determinantes pronósticos para el primer episodio psicótico y su relación con esquizofrenia.
Resultados. Se revisaron 161 artículos que cumplían con los criterios de búsqueda y que se ajustaban con el propósito del estudio.
Conclusiones. El tiempo de psicosis no tratada (DUP), el nivel del funcionamiento premórbido, la presencia o predominio de síntomas negativos, el consumo comórbido de sustancias psicoactivas y el estado psicosocial fueron las características mas influyentes para el desarrollo de la esquizofrenia, en los pacientes que presentaban un primer episodio psicótico.

Objective. Reviewing the available literature regarding prognosis for first psychotic episode for developing schizophrenia.
Method. A systematic review of studies which have evaluated prognostic determinants for the first psychotic episode and its relationship to schizophrenia was made.
Results. 161 articles were reviewed which fulfilled the search criteria and which were adjusted to the purpose of the study.
Conclusions. Duration of untreated psychosis (DUP), pre-morbid functioning level, the presence or predominance of negative symptoms, co-morbid consumption of psychoactive substances and psychosocial state were the most influential characteristics for developing schizophrenia in patients presenting a first psychotic episode.

Referencias

Murray CJ, Lopez AD. The global burden of disease and injury series, volume 1: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge, MA: Harvard University Press; 1996.

Beaglehole R, Irwin A, Prentice T, Informe sobre la salud en el mundo 2003: Forjemos el futuro. OMS; 2003. Report No.: 9.

Meltzer HY, Hossein-Fatemi S. Schizophrenia. In: Ebert MH, Loosen PT, Nurcombe B, editors. Current diagnosis & treatment in psychiatry; 2006.

Lauriello J, Bustillo JR, Keith SJ. Schizophrenia: Scope of the Problem. In: Sadock BJ, Sadock VA, editors. Kaplan & Sadock's Comprehensive Textbook of Psychiatry. 8 ed. Philadelphia: Lippincott Williams & Wilikins; 2003.

Robinson DG, Woerner MG, McMeniman M, Mendelowitz A, Bilder RM. Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry 2004 Mar;161(3):473-9.

Singh SP, Croudace T, Amin S, Kwiecinski R, Medley I, Jones PB, et al. Three-year outcome of first-episode psychoses in an established community psychiatric service. Br J Psychiatry 2000 Mar;176:210-6.

Zhang-Wong J, Beiser M, Bean G, Iacono WG. Five-year course of schizophreniform disorder. Psychiatry Res 1995 Nov 29;59(1-2):109-17.

Pillmann F, Haring A, Balzuweit S, Marneros A. A comparison of DSM-IV brief psychotic disorder with "positive" schizophrenia and healthy controls. Compr Psychiatry 2002 Sep;43(5):385-92.

Rosenheck R, Leslie D, Keefe R, McEvoy J, Swartz M, Perkins D, et al. Barriers to employment for people with schizophrenia. Am J Psychiatry 2006 Mar;163(3):411-7.

Freeman H., Katschnig H., H.Sartorius. Calidad de Vida en los Trastornos mentales. Barcelona: Masson; 2000.

Law CW, Chen EY, Cheung EF, Chan RC, Wong JG, Lam CL, et al. Impact of untreated psychosis on quality of life in patients with first-episode schizophrenia. Quality of Life Research 2005 Oct;14(8):1803-11.

Russo J, Roy-Byrne P, Jaffe C, Ries R, Dagadakis C, Avery D. Psychiatric status, quality of life, and level of care as predictors of outcomes of acute inpatient treatment. Psychiatric Services 1997;48(11):1427-34.

Malla A, Payne J. First-episode psychosis: psychopathology, quality of life, and functional outcome. Schizophr Bull 2005 Jul;31(3):650-71.

Birchwood M, Todd P, Jackson C. Early intervention in psychosis. The critical period hypothesis. Br J Psychiatry Suppl 1998;172(33):53-9.

Larsen TK, McGlashan TH, Moe LC. First-episode schizophrenia: I. Early course parameters. Schizophr Bull 1996;22(2):241-56.

Penn DL, Waldheter EJ, Perkins DO, Mueser KT, Lieberman JA. Psychosocial treatment for first-episode psychosis: a research update. Am J Psychiatry 2005 Dec;162(12):2220-32.

Malla AK, Norman RM, Joober R. First-episode psychosis, early intervention, and outcome: what have we learned? Can J Psychiatry 2005 Dec;50(14):881-91.

Loebel AD, Lieberman JA, Alvir JM, Mayerhoff DI, Geisler SH, Szymanski SR. Duration of psychosis and outcome in first-episode schizophrenia. Am J Psychiatry 1992 Sep;149(9):1183-8.

Larsen TK, Johannessen JO, Opjordsmoen S. First-episode schizophrenia with long duration of untreated psychosis. Pathways to care. Br J Psychiatry Suppl 1998;172(33):45-52.

McGlashan TH. Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course? Biol Psychiatry 1999 Oct 1;46(7):899-907.

McGorry PD. The influence of illness duration on syndrome clarity and stability in functional psychosis: does the diagnosis emerge and stabilise with time? Aust N Z J Psychiatry 1994 Dec;28(4):607-19.

Black K, Peters L, Rui Q, Milliken H, Whitehorn D, Kopala LC. Duration of untreated psychosis predicts treatment outcome in an early psychosis program. Schizophr Res 2001 Mar 1;47(2-3):215-22.

Hoff AL, Riordan H, O'Donnell DW, Morris L, DeLisi LE. Neuropsychological functioning of first-episode schizophreniform patients. Am J Psychiatry 1992 Jul;149(7):898-903.

Malla AK, Norman RM, Manchanda R, Townsend L. Symptoms, cognition, treatment adherence and functional outcome in first-episode psychosis. Psychol Med 2002 Aug;32(6):1109-19.

Joyce E, Hutton S, Mutsatsa S, Gibbins H, Webb E, Paul S, et al. Executive dysfunction in first-episode schizophrenia and relationship to duration of untreated psychosis: the West London Study. Br J Psychiatry Suppl 2002 Sep;43:s38-s44.

Kalla O, Aaltonen J, Wahlstrom J, Lehtinen V, Garcia C, I, Gonzalez de CM. Duration of untreated psychosis and its correlates in first-episode psychosis in Finland and Spain. Acta Psychiatr Scand 2002 Oct;106(4):265-75.

Barnes TR, Hutton SB, Chapman MJ, Mutsatsa S, Puri BK, Joyce EM. West London first-episode study of schizophrenia. Clinical correlates of duration of untreated psychosis. Br J Psychiatry 2000 Sep;177:207-11.

Perkins D, Lieberman J, Gu H, Tohen M, McEvoy J, Green A, et al. Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders. Br J Psychiatry 2004 Jul;185:18-24.

Wiersma D, Nienhuis FJ, Slooff CJ, Giel R. Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort. Schizophr Bull 1998;24(1):75-85.

Verdoux H, Liraud F, Bergey C, Assens F, Abalan F, van OJ. Is the association between duration of untreated psychosis and outcome confounded? A two year follow-up study of first-admitted patients. Schizophr Res 2001 Apr 30;49(3):231-41.

Perkins DO, Gu H, Boteva K, Lieberman JA. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am J Psychiatry 2005 Oct;162(10):1785-804.

Kohn D, Pukrop R, Niedersteberg A, Schultze-Lutter F, Ruhrmann S, Bechdolf A, et al. [Pathways to care: help-seeking behavior in first-episode psychosis]. Fortschr Neurol Psychiatr 2004 Nov;72(11):635-42.

Menezes NM, Milovan E. First-episode psychosis: a comparative review of diagnostic evolution and predictive variables in adolescents versus adults. Can J Psychiatry 2000 Oct;45(8):710-6.

Larsen TK, Moe LC, Vibe-Hansen L, Johannessen JO. Premorbid functioning versus duration of untreated psychosis in 1 year outcome in first-episode psychosis. Schizophr Res 2000 Sep 29;45(1-2):1-9.

Escobar R. Primer episodio psicótico. Avances en psiquiatría biológica 2000;1:46-55.

Andreasen NC, Flaum M. Schizophrenia: the characteristic symptoms. Schizophr Bull 1991;17(1):27-49.

Novak-Grubic V, Tavcar R. Predictors of noncompliance in males with first-episode schizophrenia, schizophreniform and schizoaffective disorder. Eur Psychiatry 2002 May;17(3):148-54.

Thompson KN, McGorry PD, Harrigan SM. Reduced awareness of illness in first-episode psychosis. Compr Psychiatry 2001 Nov;42(6):498-503.

Strakowski SM, Tohen M, Stoll AL, Faedda GL, Mayer PV, Kolbrener ML, et al. Comorbidity in psychosis at first hospitalization. Am J Psychiatry 1993 May;150(5):752-7.

Lambert M, Conus P, Lubman DI, Wade D, Yuen H, Moritz S, et al. The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis. Acta Psychiatr Scand 2005 Aug;112(2):141-8.

Wade D, Harrigan S, Edwards J, Burgess PM, Whelan G, McGorry PD. Course of substance misuse and daily tobacco use in first-episode psychosis. Schizophr Res 2006 Jan 31;81(2-3):145-50.

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Aust N Z J Psychiatry 2005 Jan;39(1-2):1-30.

Lambert M, Conus P, Lambert T, McGorry PD. Pharmacotherapy of first-episode psychosis. Expert Opin Pharmacother 2003 May;4(5):717-50.

Walter G, Wiltshire C, Anderson J, Storm V. The pharmacologic treatment of the early phase of first-episode psychosis in youths. Can J Psychiatry 2001 Nov;46(9):803-9.

Apiquian R, Fresan A, Herrera K, Ulloa RE, Loyzaga C, de lF-S, et al. Minimum effective doses of haloperidol for the treatment of firstpsychotic episode: a comparative study with risperidone and olanzapine. Int J Neuropsychopharmacol 2003 Dec;6(4):403-8.

Cullberg J, Levander S, Holmqvist R, Mattsson M, Wieselgren IM. One-year outcome in first episode psychosis patients in the Swedish Parachute project. Acta Psychiatr Scand 2002 Oct;106(4):276-85.

Zhang-Wong J, Zipursky RB, Beiser M, Bean G. Optimal haloperidol dosage in first-episode psychosis. Can J Psychiatry 1999 Mar;44(2):164-7.

Van Os J, Andreasen NC, Flaum M. From first episode to long-term care: The need for sustained clinical commitment. International Journal of Psychiatry in Clinical Practice 2000;4(S):19-24.

Lewis R. Typical and atypical antipsychotics in adolescent schizophrenia: efficacy, tolerability, and differential sensitivity to extrapyramidal symptoms. Can J Psychiatry 1998 Aug;43(6):596-604.

Woerner MG, Robinson DG, Alvir JM, Sheitman BB, Lieberman JA, Kane JM. Clozapine as a first treatment for schizophrenia. Am J Psychiatry 2003 Aug;160(8):1514-6.

Duggan L, Fenton M, Rathbone J, Dardennes R, El-Dosoky A, Indran S. Olanzapine for schizophrenia. Cochrane Database Syst Rev 2005;(2):CD001359.

Bradford DW, Perkins DO, Lieberman JA. Pharmacological management of first-episode schizophrenia and related nonaffective psychoses. Drugs 2003;63(21):2265-83.

Gardner DM, Baldessarini RJ, Waraich P. Modern antipsychotic drugs: a critical overview. CMAJ 2005 Jun 21;172(13):1703-11.

Cómo citar

APA

Cano, J. F., Fierro-Urresta, M., Vanegas, C. R., Alzate, M., Olarte, A., Cendales, R. & Córdoba, R. N. (2007). Factores pronósticos de esquizofrenia en primer episodio psicótico. Revista de Salud Pública, 9(3), 455–464. https://revistas.unal.edu.co/index.php/revsaludpublica/article/view/96513

ACM

[1]
Cano, J.F., Fierro-Urresta, M., Vanegas, C.R., Alzate, M., Olarte, A., Cendales, R. y Córdoba, R.N. 2007. Factores pronósticos de esquizofrenia en primer episodio psicótico. Revista de Salud Pública. 9, 3 (jul. 2007), 455–464.

ACS

(1)
Cano, J. F.; Fierro-Urresta, M.; Vanegas, C. R.; Alzate, M.; Olarte, A.; Cendales, R.; Córdoba, R. N. Factores pronósticos de esquizofrenia en primer episodio psicótico. Rev. salud pública 2007, 9, 455-464.

ABNT

CANO, J. F.; FIERRO-URRESTA, M.; VANEGAS, C. R.; ALZATE, M.; OLARTE, A.; CENDALES, R.; CÓRDOBA, R. N. Factores pronósticos de esquizofrenia en primer episodio psicótico. Revista de Salud Pública, [S. l.], v. 9, n. 3, p. 455–464, 2007. Disponível em: https://revistas.unal.edu.co/index.php/revsaludpublica/article/view/96513. Acesso em: 28 dic. 2025.

Chicago

Cano, Juan F., Marco Fierro-Urresta, Claudia R. Vanegas, Marcela Alzate, Ana Olarte, Ricardo Cendales, y Rodrigo N. Córdoba. 2007. «Factores pronósticos de esquizofrenia en primer episodio psicótico». Revista De Salud Pública 9 (3):455-64. https://revistas.unal.edu.co/index.php/revsaludpublica/article/view/96513.

Harvard

Cano, J. F., Fierro-Urresta, M., Vanegas, C. R., Alzate, M., Olarte, A., Cendales, R. y Córdoba, R. N. (2007) «Factores pronósticos de esquizofrenia en primer episodio psicótico», Revista de Salud Pública, 9(3), pp. 455–464. Disponible en: https://revistas.unal.edu.co/index.php/revsaludpublica/article/view/96513 (Accedido: 28 diciembre 2025).

IEEE

[1]
J. F. Cano, «Factores pronósticos de esquizofrenia en primer episodio psicótico», Rev. salud pública, vol. 9, n.º 3, pp. 455–464, jul. 2007.

MLA

Cano, J. F., M. Fierro-Urresta, C. R. Vanegas, M. Alzate, A. Olarte, R. Cendales, y R. N. Córdoba. «Factores pronósticos de esquizofrenia en primer episodio psicótico». Revista de Salud Pública, vol. 9, n.º 3, julio de 2007, pp. 455-64, https://revistas.unal.edu.co/index.php/revsaludpublica/article/view/96513.

Turabian

Cano, Juan F., Marco Fierro-Urresta, Claudia R. Vanegas, Marcela Alzate, Ana Olarte, Ricardo Cendales, y Rodrigo N. Córdoba. «Factores pronósticos de esquizofrenia en primer episodio psicótico». Revista de Salud Pública 9, no. 3 (julio 1, 2007): 455–464. Accedido diciembre 28, 2025. https://revistas.unal.edu.co/index.php/revsaludpublica/article/view/96513.

Vancouver

1.
Cano JF, Fierro-Urresta M, Vanegas CR, Alzate M, Olarte A, Cendales R, Córdoba RN. Factores pronósticos de esquizofrenia en primer episodio psicótico. Rev. salud pública [Internet]. 1 de julio de 2007 [citado 28 de diciembre de 2025];9(3):455-64. Disponible en: https://revistas.unal.edu.co/index.php/revsaludpublica/article/view/96513

Descargar cita

Visitas a la página del resumen del artículo

61

Descargas

Los datos de descargas todavía no están disponibles.

Licencia

Creative Commons License

Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.

Esta revista provee acceso libre inmediato a su contenido bajo el principio de que hacer disponible gratuitamente investigación al publico apoya a un mayor intercambio de conocimiento global.

Todos los contenidos de esta revista, excepto dónde está identificado, están publicados bajo una Licencia Creative Commons Atribución 4.0.